FGF18 signaling in the hair cycle resting phase determines radioresistance of hair follicles by arresting hair cycling  by Kawano, Mitsuko et al.
Advances in Radiation Oncology (2016) 1, 170-181www.advancesradonc.orgBiology ContributionFGF18 signaling in the hair cycle resting phase
determines radioresistance of hair follicles by
arresting hair cycling
Mitsuko Kawano PhD a, Sachiko Umeda BS a, Takeshi Yasuda PhD a,
Mayumi Fujita PhD a, Atsuko Ishikawa BS b, Toru Imamura PhD a,c,d,
Takashi Imai PhD e, Fumiaki Nakayama MD, PhD a,*
a Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological
Sciences, Chiba, Japan
b Department of Radiation Effects Research, National Institute of Radiological Sciences, Chiba,
Japan
c Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial
Science and Technology, Tsukuba, Japan
d School of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Japan
e Medical Databank Section, Hospital, National Institute of Radiological Sciences, Chiba, JapanReceived 7 January 2016; received in revised form 24 May 2016; accepted 27 May 2016Abstract
Purpose: Telogen (resting phase) hair follicles (HFs) are more radioresistant than their anagen
(growth phase) counterparts. Fibroblast growth factor (FGF) 18 is strongly expressed in telogen HFs
to maintain the telogen phase, whereas several other FGFs exert radioprotective effects; however,
the role of FGF18 in the radioresistance of HFs remains unknown. This study focused on clarifying
the role of FGF18 in the radioresistance of telogen HFs and its potential as a radioprotector.
Methods and materials: BALB/c mice with telogen or plucking-induced anagen HFs were
exposed to total body irradiation with g-rays at 4 to 12 Gy after intraperitoneal treatment with
FGF18 or an FGF receptor inhibitor. A time course analysis was performed histologically and hair
growth was observed 14 or 15 days after depilation. Skin specimens were analyzed by DNA
microarrays and Western blotting.
Results: Telogen irradiation at 6 Gy resulted in transient cell growth arrest, leading to successful
hair growth, whereas anagen irradiation failed to promote hair growth. Telogen irradiation did not
induce apoptosis in HFs or reduce HF stem cells, whereas anagen irradiation induced apoptosis and
reduced stem cell numbers. The Inhibition of FGF receptor signaling during the telogen phase
promoted HF cell proliferation; however, hair failed to grow after irradiation. In contrast,
recombinant FGF18 induced transient cell growth arrest after anagen irradiation with enhancedSources of support: This work was supported in part by the Cosmetology Research Foundation and Japan Society for the Promotion of Science
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Advances in Radiation Oncology: JulyeSeptember 2016 FGF18 determines radioresistance of HFs 171DNA repair, leading to the inhibition of apoptosis, maintenance of HF stem cells, and successful
hair growth. Moreover, FGF18 reduced the expression levels of genes promoting G2/M transition
as well as the protein expression levels of cyclin B1 and cdc2 in skin, and induced G2/M arrest in
the keratinocyte cell line HaCaT.
Conclusions: These results suggest that FGF18 signaling mediates radioresistance in telogen HFs
by arresting the cell cycle, and that FGF18 has potential as a radioprotector for radiation-induced
alopecia.
Copyright ª 2016 the Authors. Published by Elsevier Inc. on behalf of the American Society for
Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Radiation therapy is one of the most effective cancer
treatments currently available; however, irradiation at
high doses causes hair loss, which may lead to cosmetic
and/or mental issues, thereby reducing the quality of life
of cancer patients. We previously investigated murine hair
follicle (HF) dystrophy induced by irradiation at relatively
high doses that cause permanent alopecia using stage-
speciﬁc histological parameters,1,2 and found that this
type of dystrophy is characterized by similar morpho-
logical changes to those of dystrophic catagen induced by
chemotherapy.3 However, temporary alopecia induced by
relatively low doses of irradiation has not yet been
examined in detail, despite its greater potential to be
treated successfully.
Radiation generally causes more damage to rapidly
dividing cells than nondividing cells.4 The radiosensi-
tivity of HFs also depends on the hair cycle stage, that is,
telogen (resting phase) matrix cells are more radio-
resistant than proliferating anagen (growth phase) cells5
because anagen HF cells are proliferating more rapidly
than telogen ones. Moreover, a previous study reported
that the expression of a DNA double-strand break (DSB)
marker was weaker in telogen HFs than in anagen HFs,
even without irradiation.6 These ﬁndings suggest that
high DNA repair activity levels may contribute to the
radioresistance of telogen HFs; however, the molecular
mechanisms underlying radioresistance during telogen
remain unknown.
The hair cycle depends on the cyclic activation of HF
stem cells, which determines the proliferation, differenti-
ation, and apoptosis of a variety of hair-forming cells. HF
stem cells are located in the bulge region of HFs and
characterized by stem cell markers such as K15 or
CD34.7-9 Fibroblast growth factors (FGFs) play a key role
in regulating the hair cycle.10 The expression of FGF18
transcripts has been shown to increase during the telogen
phase and decease during the anagen phase.11 FGF18 is
expressed in K6-positive bulge cells together with bone
morphogenetic factor 6 during telogen12 to maintain
bulge stem cell quiescence.9 In addition, FGF18 inhibits
the proliferation of hair germ cells expressing a low levelof FGF18 transcripts.13 Accordingly, FGF18 maintains
the telogen phase and determines its duration, while
simultaneously inhibiting the anagen phase.14 In
contrast, several FGFs protect against radiation-induced
damage.15-19 Moreover, a treatment with FGF7 was pre-
viously shown to increase hair survival after x-ray irra-
diation.20 However, the radioprotective effects of FGF18
have not yet been elucidated in detail.
We have investigated the involvement of FGF18 in the
radioresistance of telogen HFs in BALB/c mice and the
in vivo radioprotective effects of FGF18 on anagen HFs
using symptoms, histological parameters, and a molecular
analysis. Our results demonstrated that FGF18 mediated
the radioresistance of HFs by arresting the cell cycle
during the telogen phase and has a potential as a radio-
protector against radiation-induced alopecia.
Methods and materials
Reagents
Recombinant human FGF18 was purchased from
PeproTech (Rocky Hill, NJ) or produced as reported
previously.21 AZD4547,22 a pan-FGF receptor (FGFR)
inhibitor, was purchased from AdooQ Bioscience (Irvine,
CA). Antibodies and other reagents are listed in Table E1
(available as supplementary material online only at www.
practicalradonc.org).
Animals
Seven-week-old male BALB/c mice were depilated to
induce anagen HFs and subjected to total body irradiation
(TBI) with g-rays, as described previously (Appendix
E1).3,19 FGF18 was administered intraperitoneally in 0.5
mL of saline containing 5% mouse serum or 5 mg/mL
heparin to mice 24 hours before TBI. Dorsal skin speci-
mens were sampled over time after depilation and TBI,
and staining with hematoxylin and eosin was performed
on parafﬁn-embedded sections. Hematoxylin and
eosinestained longitudinal HF sections were photo-
graphed, and more than 1000 HFs were screened in each
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numbers (density), HF lengths, and hair bulb diameters on
the photographs (n Z 2-5). All protocols complied with
the Animal Care Guidelines of the National Institute of
Radiological Sciences and were approved by the Animal
Research Committee for Animal Experimentation of the
National Institute of Radiological Sciences.
TUNEL assay
Apoptosis was evaluated in parafﬁn-embedded sec-
tions of skin by a terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) analysis as described
previously (Appendix E1).19
BrdU assay
The 5-bromo-20-deoxyuridine (BrdU) assay was per-
formed as described previously (Appendix E1).18 Mouse
immunoglobulin G was blocked using a VECTOR
M.O.M. immunodetection kit (Vector Laboratories, CA)
according to the manufacturer’s protocol.
Western blot assay
The expression of FGF18, a cell-cycle regulator, and
DNA repair proteins in skin was analyzed by Western
blotting as described in Appendix E1. The experimental
conditions for each antibody are described in Table E1.
Microarray analysis
The messenger RNA expression proﬁles of irradiated
skin were obtained by DNA microarray analysis 4 hours
after the FGF18 pretreatment, as described in Appendix
E1. Microarray data were submitted to the National
Center for Biotechnology Information Gene Expression
Omnibus (accession no.: GSE69501).
Cell-cycle analysis
The cell cycle of the human keratinocyte cell line
HaCaT was analyzed by propidium iodide staining and
ﬂow cytometry as described in Appendix E1.
Statistical analysis
All values represent the mean  standard deviation
of results obtained from 10 samples in each mouse
(n Z 2-5), and the values in each group were compared
using analysis of variance and Fisher’s protected
least signiﬁcant difference (*P < .05; **P < .01;
***P < .001).Results
Irradiation during telogen suppresses the
development of HFs, leading to hair regeneration
BALB/c mice were subjected to TBI at anagen or
telogen to assess the radiosensitivity of HFs by hair
growth and histological parameters of HF dystrophy
(Fig 1A). Missing data depend on the radiation doses and
days after irradiation because mice were exposed to TBI
at lethal doses (Fig 1). After exposure to irradiation at 4
Gy, hair regenerated on the back 14 days after depilation.
However, anagen irradiation at more than 6 Gy markedly
delayed hair regeneration 14 days after depilation
(Fig 1B). In contrast, hair regeneration was observed on
the back 14 days after telogen irradiation at either 4 or 6
Gy (Fig 1B). Histopathologically, whole HFs were
markedly degenerated after anagen irradiation at more
than 6 Gy; this was accompanied by hair bulb shrinkage
(Fig 1C). On the other hand, follicle length was shortened
after telogen irradiation. However, signiﬁcant morpho-
logical dystrophy was not detected in HFs after telogen
irradiation at 4, 6, and 8 Gy (Fig 1C).
HF lengths were signiﬁcantly shorter in anagen- and
telogen-irradiated mice that in the nonirradiated control,
and these reductions occurred in a dose-dependent manner
(Fig 1D). HF lengths returned to the control length 9 days
after telogen irradiation at 4 Gy, but continued shortening
for up to 14 days after irradiation at 6 Gy (Fig 1D). The
hair bulb, which is the thick proximal end of HF, increases
in size until anagen IIIc and is a primary target of phar-
macological manipulations.23 Irradiation has also been
shown to inﬂuence the diameter of the hair bulb; thus, it
may be a good indicator of radiation damage.3 In the
present study, the diameter of the hair bulb decreased 3
days after anagen irradiation (Fig 1E). It then started to
increase and surpassed the diameter of the nonirradiated
control 6 days after anagen irradiation at 4 Gy. However,
the diameter of the hair bulb did not increase after anagen
irradiation at more than 6 Gy and remained smaller than
that of the nonirradiated control (Fig 1E). On the other
hand, telogen irradiation induced the growth of hair bulb
even at 6 Gy, and was slightly larger than that of the
nonirradiated control 12 days after irradiation (Fig 1E).
Irradiation during telogen arrests cell
proliferation in HFs
BALB/c mice were subjected to anagen or telogen irra-
diation to assess the proliferation and apoptosis of hair bulb
cells as well as the number of CD34þ HF stems in HFs
(Fig 2A). During anagen, HF keratinocytes strongly
proliferated in the hair bulb and continued proliferating for 3
days after anagen irradiation at 4, 6, and 8 Gy (Fig 2B). In
contrast, very few cells proliferated in HF during telogen.
Figure 1 Telogen hair follicles are radioresistant. (A) Experiment protocols of radiation-induced hair damage depending on the hair-
cycle stage. Anagen hair follicles (HFs) were irradiated 6 days after depilation (anagen irradiation), whereas telogen HFs were irra-
diated and then depilated 1 hour after irradiation (telogen irradiation). (B) BALB/c mice were subjected to total body irradiation (TBI)
during anagen or telogen with g-rays at the indicated doses. Representative appearance of skin 14 days after depilation. (C) Representative
hematoxylin and eosinestained sections of dorsal skin 8 days after TBI during anagen or telogen. HF dystrophy (yellow arrows) and
shortened HFs (double-pointed arrows) were observed after anagen and telogen irradiation, respectively. (D) Lengths of HF and (E) bulb
diameters were determined in HE-stained sections of dorsal skin after TBI. Each value is shown as a relative value from the nonirradiated
control 6 days after depilation. *P < .05; **P < .01; ***P < .001 signiﬁcantly different from the nonirradiated control.
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resulting in complete arrest 3 days after telogen irradiation at
6 Gy with postirradiation depilation (Fig 2B). Although
radiation-induced apoptosis was not detectable in the bulge
under the current experimental conditions, anagen irradia-
tion induced apoptosis in the hair bulb in a dose-dependent
manner.3 However, in contrast to anagen irradiation, telogen
irradiation did not induce apoptosis in HFs (Fig 2C). The
number of HF stem cells progressively decreased in the
bulge over time during the anagen phase (Fig E1). In
addition, anagen irradiation further reduced the number of
CD34þ and K15þ stem cells in HFs in a dose-dependent
manner (Fig 2D; Fig E2A-B). However, telogen irradia-
tion did not signiﬁcantly reduce the number of HF stem
cells, regardless of postirradiation depilation (Fig 2D; Fig
E2A-B). LGR5þ cells are actively proliferating and mul-
tipotent stem cells that are located in the lower outer sheathof anagen HFs.24 Irradiation markedly reduced LGR5þ
stem cell numbers during anagen (Fig E2C). In contrast,
LGR5þ cells in the bulge and secondary germ of telogen
HFs were maintained after irradiation (Fig E2C); therefore,
cyclic activation of HF stem cells during growth phase may
contribute to the greater radiosensitivity of stem cells.FGF signaling is critical for the radiosensitivity of
HFs
FGF18 is strongly expressed in telogen HFs; however,
its expression was markedly weaker in in HFs after the
induction of anagen by depilation and remained at low
levels up to 15 days after depilation (Fig 3A; Fig E3A).
The expression of FGF18 also correlated with that of the
telogen marker Krt24 (Fig E3AB).25 FGF18 regulates the
Figure 2 Proliferation of hair follicle (HF) cells is arrested after telogen irradiation. (A) Protocols of experiments following anagen or
telogen irradiation. Telogen irradiation was performed without depilation for CD34 staining. (B) The cell proliferation of HFs was
examined by the incorporation of 5-bromo-20-deoxyuridine (BrdU) 3 days after irradiation at the indicated doses. (C) Terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays were performed using parafﬁn-embedded sections 24 hours after
irradiation. (D) Staining with an anti-CD34 antibody was performed on frozen sections 3 days after anagen or telogen irradiation at the
indicated doses to evaluate reductions in HF stem cell numbers. In addition, experiments were performed without the induction of
anagen by depilation after irradiation at telogen.
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Figure 3 Inhibition of ﬁbroblast growth factor receptor (FGFR) signaling increases the radiosensitivity of telogen hair follicles (HFs).
(A) The protein expression level of ﬁbroblast growth factor 18 (FGF18) over time in skin was examined by Western blot analysis after
depilation. (B) The relative number of 5-bromo-20-deoxyuridine (BrdUþ) cells in HFs was examined 24 hours after depilation. One
hundred micrograms of FGF18 was administered intraperitoneally 1 hour before depilation. (C) Protocol of experiments using the FGFR
inhibitor AZD4547. Five hundred microliters of 0.5 mM AZD4547 was administered intraperitoneally 24 hours before telogen irra-
diation. (D) Representative appearance of skin 14 days after irradiation at 6 Gy. (E) Representative hematoxylin and eosin (HE)-stained
sections of dorsal skin 7 and 14 days after irradiation. HF dystrophy was observed 14 days after telogen irradiation with the AZD4547
pretreatment (yellow arrow). (F) Staining with an anti-K15 antibody was performed using parafﬁn-embedded sections 3 days after
irradiation. (G) Cell proliferation in HFs, (H) relative lengths of HFs, and (I) relative bulb diameters were examined over time after TBI.
*P < .05; **P < .01; ***P < .001.
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the anagen phase,14 and compensation by FGF18 inhibited
depilation-induced cell proliferation in HFs (Fig 3B).
Therefore, the involvement of FGF in radiation-inducedHF damage was examined by administrating an FGFR
inhibitor to mice during telogen (Fig 3C). The FGFR in-
hibitor (AZD4547) suppressed hair growth after telogen
irradiation (Fig 3D). In contrast, the FGFR inhibitor
Figure 4 Exogenous FGF18 protects hair follicle (HF) keratinocytes and stem cells from radiation-induced damage. (A) Protocol of
experiments after the administration of recombinant ﬁbroblast growth factor 18 (FGF18). One hundred micrograms of FGF18 was
administered intraperitoneally 24 hours before anagen irradiation. (B) Staining with an anti-gH2AX antibody was performed using
parafﬁn-embedded sections 1, 4, and 24 hours after anagen irradiation to evaluate the repair of DNA double-strand breaks in hair bulb
cells. (C) Staining with anti-K15 and anti-CD34 antibodies was performed 24 hours after irradiation at 12 Gy to detect HF stem cells.
(D) The number of HF CD34þ cells was assessed in the HF bulge and secondary hair germ 24 hours after irradiation at 12 Gy. Each
value is shown as a relative value from the number of cells in the nonirradiated saline control. (E) Apoptosis was determined by terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays 24 hours after anagen irradiation. (F) Cell proliferation in HFs was
examined by the incorporation of 5-bromo-20-deoxyuridine (BrdU) 4 hours after irradiation at 6 Gy. *P< .05; **P < .01; ***P < .001.
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but induced morphological dystrophy in HFs 14 days after
irradiation (Fig 3E). In addition, the FGFR inhibitor
slightly decreased the number of K15þ stem cells in HFs
without irradiation because the inhibition of FGFR during
telogen induced the anagen phase instead of depilation (Fig
3F). The FGFR inhibitor increased the incorporation of
BrdU into HF cells and slightly enhanced the elongation of
HFs 7 days after irradiation, which were shorter 14 days
postirradiation than the irradiated control (Fig 3G-H).
Similar to the HF length, the bulb diameter also showed a
similar change in size in response to the FGFR inhibitorand irradiation: however, these changes were not signiﬁ-
cantly different form the irradiated control (Fig 3I).
Exogenous FGF18 protects HF keratinocytes and
stem cells from radiation-induced damage
The involvement of FGF18 in the protection of HF
keratinocytes and stem cells during exposure to radiation
was examined by assessing DNA DSBs, stem cells,
apoptosis, and proliferation (Fig 4A). The expression of
gH2AX, a DSB marker,26 was enhanced HFs 1 hour after
irradiation at 6 Gy (Fig 4B); this was followed by DNA
Figure 5 Fibroblast growth factor 18 (FGF18) promotes hair regeneration after irradiation. (A) Protocol of experiments after the
administration of recombinant FGF18. One hundred micrograms of FGF18 was administered intraperitoneally 24 hours before anagen
irradiation at 6Gy. (B)Representative appearance of skin 9 days after irradiation. (C) The proportion of hair follicles (HFs) at each hair-cycle
stagewasmeasured by hematoxylin and eosin staining of dorsal skin 15 days after total body irradiation. (D) Changes in hair bulb diameters
and (E) HF lengths over time were measured after irradiation. (F) Cell proliferation in HFs was examined by the incorporation of terminal
deoxynucleotidyl transferase dUTP nick end labeling over time after irradiation. Each value is shown as a relative value from the nonir-
radiated control 6 days after depilation. *P < .05; **P < .01; ***P < .001 signiﬁcantly different from the nonirradiated control.
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Figure 6 Fibroblast growth factor 18 (FGF18) enhances G2/M arrest in keratinocytes. (A-D) One hundred micrograms of FGF18 was
administered intraperitoneally 24 hours before anagen irradiation at 6 Gy. (A) Total RNA was isolated from skin 4 hours after total body
irradiation (TBI). The expression levels of each gene in FGF18-treated mice relative to those in saline-treated mice were measured by
DNA microarrays. (B) The expression levels of genes promoting G2/M transition were measured by DNA microarrays. (CD) Cell
lysates were prepared from dorsal skin specimens isolated 1 and/or 4 hours after TBI and subjected to a Western blot analysis using
anti-cyclin B1, anti-cdc2, anti-phospho-cdc2 (Tyr15), and anti-Rad51 antibodies. (E) The cell-cycle distribution of HaCaT cells was
examined 3, 6, and 24 hours after the treatment with 100 ng/mL FGF18 by propidium iodide (PI) staining using ﬂow cytometry. The
ratio of G2/M to G1 cell numbers was calculated. (F) The cell-cycle distributions of HaCaT-mock and HaCaT-FGFR3c transfectants
were examined by PI staining using ﬂow cytometry 24 hours after the treatment with 100 ng/mL FGF18. (G) FGF18 is expressed in K6-
positive bulge cells12 to maintain bulge stem cell quiescence9. FGF18 signaling mediates the relationship between radioresistance
and the hair-cycle stage. FGF18 plays a key role in both the resting state of hair follicles (HFs) and cell-cycle arrest of HF cells for DNA
repair. In addition, the recombinant FGF18 protein promotes the regeneration of HFs after irradiation by enhancing the repair of HF
damage through the slowing of hair cycling. mRNA, messenger RNA.
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gH2AX foci 24 hours postexposure. A pretreatment with
recombinant FGF18 reduced gH2AX foci in the HFs 4
hours after irradiation (Fig 4B). However, FGF18 did not
affect gH2AX foci 1 hour after TBI, suggesting that it is
associated with DSB repair, but not the induction of
DSBs. The application of FGF18 also inhibited reduction
in K15þ and CD34þ stem cell numbers after irradiation
(Fig 4CD) and decreased radiation-induced apoptosis in
the hair bulb (Fig 4E); thus, FGF18 may protect stem and
progenitor cells in anagen HFs against radiation damage.
On the other hand, the number of BrdU-labeled cells in
FGF18-treated mice was decreased to 50% of that in
control mice (Fig 4F). These results suggest that the
administration of FGF18 may arrest the growth of HFs
during anagen, resulting in increases in DNA repair and
cell survival in the hair bulb and HF stem cells.
FGF18 promotes hair regeneration after radiation
damage
The effects of FGF18 on hair regeneration after irra-
diation were examined in anagen HFs (Fig 5A). Although
anagen irradiation at 6 Gy delayed hair regeneration,
exogenous FGF18 induced successful hair growth even
after anagen irradiation at 6 Gy (Fig 5B). Irradiation
during anagen increased anagen-catagen transition and
increased the number of catagen HFs 15 days after
depilation; however, the FGF18 treatment suppressed the
radiation-induced anagen-catagen transition of HFs (Fig
5C). The FGF18 treatment decreased the hair bulb
diameter more than the saline treatment 3 days after
irradiation; this was followed by full recovery (Fig 5D).
Moreover, the HF length was reduced by the FGF18
treatment 3 days after irradiation; this was followed by an
increase in size to more than that of the control without
the FGF18 treatment (Fig 5E). Irradiation transiently
reduced the number of proliferating cells in hair bulbs to
approximately 50% that in the nonirradiated control (Fig
5F). The FGF18 treatment reduced the number of
proliferating cells after anagen irradiation more signiﬁ-
cantly than in the irradiated control, which maintained a
lower level of proliferation for a longer duration than the
irradiated control. Accordingly, the time course of HF
development during the FGF18 treatment was similar to
the pattern of the successful regrowth of HFs, including
the early suppression and late overgrowth stages (Fig 1E).
FGF18 induces G2/M arrest in keratinocytes to
mediate the radioresistance of HFs
The FGF18 treatment promoted the repair of DNA
damage by reducing DSBs in the HFs (Fig 4B). DSBs
are the most frequently induced and harmful type of
DNA damage incurred by irradiation and are repaired bynonhomologous end joining or homologous recombina-
tion through the assembly of DNA repair molecules.27
To screen for molecules involved in FGF18-induced
radioresistance, the messenger RNA expression proﬁles
of irradiated skin were obtained using a DNA microarray
analysis 24 hours after the FGF18 pretreatment. The
expression levels of genes that promote G2/M transition,
Cdk7, Cdk1 (cdc2), and Ccnb1 (cyclin B1), were lower
than those in the control, whereas those of genes that
promote G1 phase progression, Cdk4, Ccnd2 (cyclin
D2), and Ccnd1 (cyclin D1), were higher (Fig 6A-B and
Fig E4A). In addition, the pretreatment with FGF18
reduced the protein expression of cyclin B1 and cdc2 in
skin (Fig 6C). Although the dephosphorylation of cdc2
(Tyr 15), a marker of the activation of cdc2, was
observed after the FGF18 treatment, it may have been
due to compensation for the reduction in cdc2 protein
levels. These results suggest that FGF18 promotes G2/M
arrest in skin after irradiation, because G2/M transition
is tightly regulated by the cdc2/cyclin B complex.28 In
contrast, the FGF18 treatment did not increase the
expression of DNA repair genes in skin (Fig E4B). The
protein expression of Rad51, which plays an essential
role in DNA repair by homologous recombination,27 did
not increase in skin or HFs after the FGF18 treatment
(Fig 6D; Fig E5).
FGF18 induced cell-cycle arrest at G2/M in HaCaT
keratinocytes 3, 6, and 24 hours after the addition of
FGF18 (Fig 6E). Furthermore, transfection of the human
FGFR3c gene into HaCaT cells increased the G2/M
population without the addition of FGF18 (Fig 6F)
because FGFR3c is a receptor of FGF18.29 The G2/M
arrest induced in HaCaT keratinocytes by FGF18 was
consistent with the reduced expression of cdc2 and
cyclin B1 in skin after anagen irradiation with the FGF18
pretreatment (Fig 6A-C).Discussion
DNA damage arrests cell-cycle progression, which
provides cells with time to repair the damage induced.30
In the present study, successful hair growth after anagen
irradiation was characterized by the morphological pattern
of HF changes, namely early suppression and late growth
stages (Fig 1E). A similar pattern of HF changes was
observed after telogen irradiation at 6 Gy, which resulted
in hair regrowth (Fig 1E). In contrast, FGF18 was
strongly expressed during telogen (Fig 3A; Fig E3A),11
and has been shown to play an essential role in the
maintaining the telogen phase.14 Moreover, the inhibition
of FGFR induced a reversal in the morphological pattern
of hair regrowth, comprising early growth and late sup-
pression stages (Fig 3). These results suggest that FGF18
signaling is involved in the regeneration of HFs after
irradiation through the suppression of HF development.
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recovery of HFs after irradiation because FGF18 mediated
the cessation of HF development, inhibition of apoptosis
in HF keratinocytes, and maintenance of HF stem cells,
thereby promoting the repair of HF damage (Fig 4, 5).
The rationale for these results was FGF18 enhancing
G2/M arrest in keratinocytes to provide more time for
DNA repair in these cells (Fig 6). Although FGF18-
induced G2/M arrest has not been demonstrated in cells,
FGF2 has been shown to induce G2/M arrest in Ras-
driven mouse malignant cell lines.31 FGF1 also reduces
cyclin B1/CDK1 activity to induce transient G2 arrest in
rat chondrosarcoma chondrocytes. However, the mecha-
nisms underlying FGF1-induced reductions in cyclin
B1/CDK1 have not yet been clariﬁed, but have already
been investigated in an attempt to identify the signaling
pathways responsible using several inhibitors including
an ERK1/2 inhibitor.32 Thus, further studies are needed to
identify novel signaling molecules to clarify the
involvement of FGF/FGFR signaling pathways in cell-
cycle regulation. Although FGF1 is expressed in HFs
during telogen11 and has markedly broader FGFR speci-
ﬁcity than FGF18,29 recombinant FGF1 was found to be
less effective for promoting HF regeneration after radia-
tion damage than FGF18 (data not shown). In contrast,
FGF18 has been shown to react with limited members of
FGFRs including FGFR3c29 and chondrocytes express
FGFR333; therefore, FGFR3 signaling may play a key
role in the induction of G2/M arrest by FGF18.
Although telogen HFs have a morphologically quies-
cent appearance, telogen is an energy-efﬁcient default
state for a new regeneration cycle.34 At the level of
transcriptional regulation, the expression of key compo-
nents of G2/M progression: Cdk1, Cdca2, Nek2, Cenpf,
Cenpn, and SMC2, was decreased during the telogen
phase, and this may have been because some HF cells are
arrested in G2 to enable fast anagen activation.25 During
late telogen, hair germs contain a signiﬁcantly higher
percentage of G2/M phase cells than the bulge.13 FGF18
is strongly expressed during telogen; therefore, it may
exert cytostatic effects on HF keratinocytes by inducing
G2/M arrest to provide time for the indirect promotion of
DNA repair, leading to the development of radio-
resistance in telogen HFs. FGF18 maintains bulge stem
cell quiescence9 and inhibits the proliferation of hair germ
cells that express a low level of FGF18 transcripts.13
Although irradiation reduced not only the numbers of
K15þ and CD34þ stem cells, but also that of LGR5þ
cycling stem cells during anagen (Fig 2D; Fig E2),
exogenous FGF18 maintained HF stem cell numbers after
anagen irradiation (Fig 4C-D); therefore, FGF18 may
exert cytostatic effects on not only keratinocytes, but also
HF stem cells.
Thus, FGF18 signaling mediates the relationship
between radioresistance and the hair-cycle stage because
it plays a key role in both the resting state of HFs andcell-cycle arrest of HF cells for DNA repair. Although the
expression of FGF18 decreased in HFs during anagen,
that of FGFR3 gradually increased during the anagen
phase, and this increase was enhanced by irradiation (Fig
E3C-D). Therefore, FGF18 may be more reactive to
FGFR3-expressing keratinocytes during anagen after
irradiation, and, as such, the recombinant FGF18 protein
could promote regeneration of anagen HFs by enhancing
the repair of HF damage through the slowing of hair
cycling (Fig 6G).
Accordingly, our results revealed that FGF18 mediates
the radioresistance of telogen HFs. FGF18 has potential
as a radioprotector, and its effects may provide a new
approach for the treatment and prevention of radiation-
induced alopecia.
Supplementary data
Supplementary material for this article (http://dx.doi.
org/10.1016/j.adro.2016.05.004) can be found at www.
practicalradonc.org.
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